bioAffinity Technologies, Inc.
BIAF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $6,902 | $4,227 | $11,277 |
| - Cash | $7,669 | $803 | $445 | $1,105 |
| + Debt | $285 | $670 | $1,331 | $1,501 |
| Enterprise Value | – | $6,769 | $5,113 | $11,673 |
| Revenue | $1,446 | $1,269 | $1,854 | $2,208 |
| % Growth | 13.9% | -31.5% | -16% | – |
| Gross Profit | $390 | $253 | $486 | $492 |
| % Margin | 27% | 19.9% | 26.2% | 22.3% |
| EBITDA | -$4,929 | -$3,908 | -$2,482 | -$2,788 |
| % Margin | -340.9% | -307.9% | -133.9% | -126.3% |
| Net Income | -$5,051 | -$4,061 | -$2,660 | -$2,967 |
| % Margin | -349.3% | -319.9% | -143.5% | -134.4% |
| EPS Diluted | -4.74 | -5.07 | -4.8 | -6 |
| % Growth | 6.5% | -5.6% | 20% | – |
| Operating Cash Flow | -$2,480 | -$2,647 | -$1,642 | -$1,677 |
| Capital Expenditures | $4 | -$13 | -$51 | -$0 |
| Free Cash Flow | -$2,477 | -$2,661 | -$1,693 | -$1,677 |